GRIFOLS | GRF - Ordinary Share Capital


GRIFOLS reported EUR680.58M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alcon AG USD 487.4M 0 Mar/2026
Almirall EUR 214.79M 0 Dec/2025
Amadeus IT EUR 422.35M 8.56M Mar/2026
Amarin USD 20.81M 13K Dec/2025
AstraZeneca USD 1.55B 73K Mar/2026
Bayer EUR 982.42M 0 Dec/2025
Cie Automotive EUR 118.62M 1.1M Dec/2025
Demant DKK 210.9M 5.18M Dec/2025
Ence Energia y Celulosa EUR 242.25M 177.27K Dec/2025
Essilor EUR 463.05M 1.9M Dec/2025
Ferrovial EUR 720.63M 1.07M Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Inditex EUR 3.12B 0 Mar/2026
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.91B 60K Mar/2026
Philips EUR 952.02M 729K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Smith & Nephew USD 875.96M 1.61M Dec/2025
UCB EUR 190.36M 365.15K Dec/2025
Viscofan EUR 46.88M 0 Mar/2026